mitoxantrone and Chronic Fatigue and Immune Dysfunction Syndrome studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research Excerpts

Excerpt	Relevance	Reference
"The pathophysiology of chronic fatigue syndrome is unknown, however activation of immune, inflammatory, oxidative and nitrosative stress mechanisms and plasma lipid peroxide elevation was reported."	6.82	Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and mitoxantrone. ( Adamczyk, J; Adamczyk-Sowa, M; Misiolek, H; Niedziela, N; Owczarek, M; Sowa, P; Zwirska-Korczala, K, 2016)
"The pathophysiology of chronic fatigue syndrome is unknown, however activation of immune, inflammatory, oxidative and nitrosative stress mechanisms and plasma lipid peroxide elevation was reported."	2.82	Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and mitoxantrone. ( Adamczyk, J; Adamczyk-Sowa, M; Misiolek, H; Niedziela, N; Owczarek, M; Sowa, P; Zwirska-Korczala, K, 2016)

Research

Studies (1)

Authors

Trials

1 trial available for mitoxantrone and Chronic Fatigue and Immune Dysfunction Syndrome

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors	Studies
Adamczyk-Sowa, M	1
Sowa, P	1
Adamczyk, J	1
Niedziela, N	1
Misiolek, H	1
Owczarek, M	1
Zwirska-Korczala, K	1